A recent meta-analysis of 12 studies (4 RCTs and 8 observational) performed by my group reported similar pooled odds ratios of survival rate at 1, 2 and 3 years with a decreasing trend in favor of DEB-TACE (0.76, 0.68 and 0.57, respectively)[ 55 ].
← all excerpts
Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art.
1
—
—